固生堂中医 operates a nationwide TCM clinic and primary-care chain with more than 30–31 outpatient clinics across 13 important cities and service coverage in 56 cities. The group employs roughly 1,500 TCM experts and reported about 3 million outpatient visits in 2016. Its core offering is standardized, chain‑operated TCM outpatient services combining on‑site clinics, IT systems, centralized herb procurement/quality control, and online consultation to bind patients to family‑doctor style care. Management has launched a “中医合伙人” (doctor‑partner) program that lets doctors take 30% equity in single stores, with guaranteed exit, pledgeable shares, dividend sharing, and suggested 8–10x return potential over eight years. Financially, the company has completed multiple financing rounds from domestic and foreign investors and reported total funding to date of over RMB1.7 billion. 固生堂 emphasizes integration with insurance and hospital networks, and positions itself as a mixed‑ownership, state‑backed chain to support China’s primary‑care and TCM reform goals.

Total raised

$224M

Funding rounds

3

Latest round

Debt Financing

Latest activity

Sep 2017